Literature DB >> 33999828

Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time-Series Study.

Dalia Khoury1, Alexander Preiss1, Paul Geiger1, Mohd Anwar2, Kevin Paul Conway3.   

Abstract

BACKGROUND: The opioid crisis in the United States may be exacerbated by the COVID-19 pandemic. Increases in opioid use, Emergency Medical Service (EMS) runs for opioid-related overdoses, and opioid-overdose deaths have been reported. No study has examined changes in multiple naloxone administrations, an indicator of overdose severity, during the COVID-19 pandemic.
OBJECTIVE: This study examined changes in the occurrence of naloxone administrations (NAs) and multiple naloxone administrations (MNAs) during EMS runs for opioid-related overdoses during the COVID-19 pandemic in Guilford County, North Carolina (NC).
METHODS: Using a period-over-period approach, we compared the occurrence of opioid-related EMS runs, NAs, and MNAs during the 29-week period before (September 1, 2019 to March 9, 2020) and after NC's COVID-19 state-of-emergency declaration (i.e., the 'COVID-19 period' of 3/10/2020 to 9/30/2020). Furthermore, historical data were used to generate a quasi-control distribution of period-over-period changes to compare the occurrence of each outcome during the COVID-19 period to each 29-week period back to January 1, 2014.
RESULTS: All outcomes increased during the COVID-19 period. Compared to the previous 29 weeks, the COVID-19 period experienced increases in the weekly mean number of opioid-related EMS runs (25.6 versus 18.6, p<.001), NAs (22.3 versus 14.1, p<.001), and MNAs (5.0 versus 2.7, p<.001) corresponding to proportional increases of 37.4%, 57.8%, and 84.8%, respectively. Additionally, the increases during the COVID-19 period were greater than 91% of all historical 29-week periods analyzed.
CONCLUSIONS: The occurrence of EMS runs for opioid-related overdoses as well as NAs and MNAs during EMS runs increased during the COVID-19 pandemic in Guilford County, NC. For a host of reasons that need to be explored, the COVID-19 pandemic appears to exacerbate the opioid crisis.

Entities:  

Year:  2021        PMID: 33999828     DOI: 10.2196/29298

Source DB:  PubMed          Journal:  JMIR Public Health Surveill        ISSN: 2369-2960


  7 in total

Review 1.  Noradrenergic circuits and signaling in substance use disorders.

Authors:  Anthony M Downs; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2022-02-14       Impact factor: 5.273

2.  Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care.

Authors:  Gabriel Vallecillo; Francina Fonseca; Lina Oviedo; Xavier Durán; Ignacio Martinez; Alexandra García-Guix; Claudio Castillo; Marta Torrens; Santiago Llana; Albert Roquer; Maria de la Cabeza Martinez; Sandra Aguelo; Irene Canosa
Journal:  Drug Alcohol Depend Rep       Date:  2022-01-15

Review 3.  Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.

Authors:  Anh Truc Vo; Thomas Patton; Amy Peacock; Sarah Larney; Annick Borquez
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

4.  Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada.

Authors:  Kenneth A Feder; JinCheol Choi; Catherine G Schluth; Kanna Hayashi; Kora DeBeck; Michael-John Milloy; Gregory D Kirk; Shruti H Mehta; Michele Kipke; Richard D Moore; Marianna K Baum; Steven Shoptaw; Pamina M Gorbach; Brian Mustanski; Marjan Javanbakht; Suzanne Siminski; Becky L Genberg
Journal:  Drug Alcohol Depend       Date:  2022-06-24       Impact factor: 4.852

5.  "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.

Authors:  Sarah Bauerle Bass; Patrick J A Kelly; Sphoorti Pandit-Kerr; Jenine Pilla; Katherine Morris; Erin Larsen; Jennifer P Wisdom; Phillip R Torralva
Journal:  Front Public Health       Date:  2022-07-22

6.  Maine's Overdose Prevention Through Intensive Outreach, Naloxone and Safety (OPTIONS) Initiative.

Authors:  Amy Carter; Daniel S Soucier; Eric Haram; Sybil Mazerolle; Michael Sauschuck; Katherine Coutu-Farrell
Journal:  J Public Health Manag Pract       Date:  2022 Nov-Dec 01

7.  Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018.

Authors:  Kevin P Conway; Dalia Khoury; Rainer Hilscher; Arnie P Aldridge; Stephanie J Parker; Gary A Zarkin
Journal:  Addict Sci Clin Pract       Date:  2022-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.